Downling must resign, inadequate. never gives exhaustive answers, always very vague. it is too early to say, there is not enough data, we do not have a guide, we do not know when phase 1 will start. But how do all the other organic companies that provide timings do? are they magicians?

Jazz To Acquire Cannabinoid Drug Company GW Pharma For $7.2B $JAZZ $GWPH

cbd and cannabis companies with big hikes today, except us

will have a growing turnover, our has been decreasing for a year. this assigns a very low multiplier to cvsi. if it reverses the turnover, the multiplier will increase

the drop in visits to the site is worrying, I'm sorry there are no considerations on this and we continue to talk about undervalued numbers. the market looks to the future prospects. here is several quarters that the turnover decreases

Pluscbdoil has implemented the autoship every 30 60 90 days with 20% discount

https://www.instagram.com/p/CBIrED1huK5/

https://www.rollcall.com/2020/06/04/hemp-industry-asks-congress-to-help-on-fda-guidance/

https://ir.cvsciences.com/press-releases/detail/157/cv-sciences-inc-announces-publication-of-two-research

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=%22cv+sciences%22&OS=%22cv+sciences%22&RS=%22cv+sciences%22

This example reports the results of a trial involving a group of ten individuals who were habitual and chronic users of smokeless tobacco products. Each of the ten individuals was given a supply of the chewing gum as described in Example 1 and instructed to use the gum as often as needed over a period of 24 hours. At the conclusion of this period, all of the subjects (10/10) reported that they used the chewing gum in lieu of the smokeless tobacco products they normally would have consumed; and all of the subjects (10/10) reported that the chewing gum was effective to significantly block cravings for smokeless tobacco.

Have the products on the site had a price reduction?

S3s are common to many companies. they don't say there will be a capital increase or share issue. there are s3 that remain intact until the deadline. I also remind you that in the event of reverse, the shares they have available to issue are also grouped together

https://www.similarweb.com/website/pluscbdoil.com#overview

In the quarterly report a few days ago, they said they would pause the drug development to save money. After a few days the patent arrived. it seems that the release of the patent was unexpected. maybe they didn't think it would come so fast?

now that the patent has been accepted we could also apply as a pharmaceutical company and not as a cbd sales company. we would just miss the quote above 3 4 dollars.

cweb After inventory write downs the Company reported a net loss of $18.8 million, or ($0.19) per share for the fourth quarter of 2019, compared to net income of $3.2 million, or $0.03 per share in the fourth quarter of 2018.

FDA pledges CBD regulations in 2020. ??

https://www.greenhousegrower.com/crops/cannabis/hempers-rejoice-dea-lab-requirement-revised-fda-pledges-fast-tracked-cbd-regulations/

https://www.change.org/p/food-and-drug-administration-help-veterans-and-help-yourself

there are 15,000 golf courses and 30 million players in the United States. for a total of 500 million games every year

is not active. says to put a product in the cart, but then nothing happens. or maybe I have to insert the payment methods in the registry?

I have been working in IT for 20 years. remaking a website is apparently easy. needless are other aspects not visible. the sales websites are connected with other applications, such as billing warehouse, forecasting engines. the aesthetic part could also be fast but the rest is not. they are 6/12 month projects

Is a study done in Europe recognized in America? I am aware that the FDA wants American patients

For marty: I wanted to ask why phase 1 of the drug will start in Europe and not in America. does anyone have an answer?

if fda had kept the health of the citizens would have issued a regulation even temporary a dwarf ago. instead deliberately has ruined the market of cbd making sure that healthy companies do not grow and making it lose the positive reputation of cbd with many bad actors.

New presentation
https://d1io3yog0oux5.cloudfront.net/_674ad660f5e48fee296d970efd09f06a/cvsciences/db/354/2712/pdf/CV+Sciences+Nov+2019+Investor+Deck%281%29.pdf

it's easy not to lose sales, put the price at 50% discount, keep the turnover but consume millions of dollars in cash. unfortunately cvsi cannot afford this. we are in otc and we cannot find money from adc

why start phase 1 in europe and not in Usa? this thing is strange

why the phase 1 study will be done in europe? puzzles me that it is not done in america

18732000

do you measure the capitalization of this type of company from turnover? then the bio should be worth a tenth of what they are worth? these types of companies value themselves from future growth, from potential.

https://www.newhope.com/people-and-company-profiles/how-cv-sciences-prepared-success-hemp-cbd-category

Safe banking act passed!

There only 80 votes worth votes in 160

the new products had to be 4, instead they are 7. why do you think?

does anyone know if they presented the new products at the September conference? I didn't hear anything about it

http://www.pazzosognofinanza.com/pg.php?pag=grafici&op=dettaglio&id=170866

therefore for the cvsi analyst it is worth 500 million and cweb 2.5 bilion. what would be the reason?

https://247wallst.com/consumer-products/2019/08/08/youll-be-surprised-by-how-many-americans-use-cbd-products/

to think that amazon for years produced only losses, and analysts complained every quarterly. look where it is now